10 Best Dividend Paying Drug Manufacturing Stocks

The best dividend paying stocks from the major drug manufacturing industry originally published at "long-term-investments.blogspot.com". The healthcare sector is another great investment field for me. I mainly like it because of the ongoing aging population. The older people are, the more healthcare they need. The big problem is that most of the people don’t have saved enough money to finance all their health services and products - The government must care for it and makes it via health care plans, insurance, hospitals, education and so on. This means also a state related dependence for the investor.

One of the best yielding industries within the healthcare sector is the major drug manufacturing industry. The average yield amounts to 3.85 percent and the P/E’s on a level of 18.0. The industry has exactly 10 dividend stocks and is still the biggest investment field followed by a ten times smaller Biotechnology industry. I believe that the biotech's will perform better and catch up to the leading industry unless the old drug companies will not overtake them. The reason is simple: They are more innovative.

However, below is a small list of the best dividend paying major drug manufacturing stocks. From 10 stocks have seven with a buy or even better rating. Despite the great predictions of decreasing sales and earnings due to patent losses, growth is still forecasted for the most of the drug dividend stocks.

The Best Healthcare Growth Picks Of The Next Five Years

Healthcare Dividend Stocks With Highest Expected EPS Growth Researched By “long-term-investments.blogspot.com”. I like healthcare companies because the sector is a long-term growth area due to the ongoing aging population. The sector is a 46.1 trillion bet on stronger than expected health diseases with a current dividend yield of 3.20 percent. We know that the sector is very political driven because heath is a question of cost and money. 80 percent of the world’s population cannot finance a solid medical-aid, medical-care ore even an old-care. The best dividend stocks within the sector still come from the major drug manufacturing industry as well as from the medical practitioners industry.

I made a little screen of the best large capitalized stocks with the highest expected earnings per share growth for the next five years. The industry with the biggest earnings forecast is definitely the biotechnology industry, followed by medical appliances and equipment stocks. But those companies pay no dividends. I focused on stocks with a positive yield and a double-digit earnings growth. Finally, fourteen companies remained of which all are currently recommended to buy. The mostly represented companies are from the healthcare plans industry.

10 Best Yielding Drug Manufacturing Stocks

Major Drug Manufacturing Stocks With Highest Yields Researched By Dividend Yield - Stock, Capital, Investment. The major drug manufacturing industry is very interesting for dividend investors due to high yielding stocks. The great burdens within the industry are expected patent losses as well slowing growth. But prices for the most big drug companies are very attractive in relation to the offered risks. However, I screened the healthcare sector by the best yielding major drug companies. Ten stocks remained of which five yielding over four percent and seven are currently recommended to buy. One high yield is below the results.

7 Most Profitable Healthcare Dividend Stocks With Great Yields

Healthcare Dividend Stocks With High Return On Investments And Big Operating Margins Researched By Dividend Yield - Stock, Capital, Investment. Healthcare dividend stocks delivered a fantastic return over the recent twenty years. Now, they are struggling due to the fact that most of their patents are drain off within the upcoming years. They have no serious alternative to compensate the expected revenue losses and to drive growth. Companies with high margins will survive the consolidation best. Here is a little screen of dividend stocks from the healthcare sector that have the best margins and returns. Both measured by a return on investment and an operating margin of more than 20 percent. Seven stocks fulfilled these criteria of which five come from the drug manufacturing industry. Also five have a current buy or better recommendation.

The 10 Best Dividend Paying Drug Stocks

Best Dividend Paying Drug Stocks by Dividend Yield - Stock, Capital, Investment. Here is a current sheet stocks from major drug manufacturing industry with positive dividend yield. 36 stocks are listed within the industry and they have a total market capitalization of USD 39.4 trillion. Only 10 of them pay dividends.

Here are the 3 top stocks by dividend yield:

(Subscribe my Blog via RSS Feed or E-Mail. Alternative, you can follow me on Facebook or Twitter)

AstraZeneca (NYSE:AZN) has a market capitalization of $63.08 billion. The company employs 61,100 people, generates revenues of $33,269.00 million and has a net income of $8,081.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $13,380.00 million. Because of these figures, the EBITDA margin is 40.22 percent (operating margin 34.55 percent and the net profit margin finally 24.29 percent).


The total debt representing 16.43 percent of the company’s assets and the total debt in relation to the equity amounts to 39.73 percent. Due to the financial situation, the return on equity amounts to 36.71 percent. Finally, earnings per share amounted to $7.29 of which $2.55 were paid in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 6.56, Price/Sales 1.87 and Price/Book ratio 2.87. Dividend Yield: 5.71 percent. The beta ratio is 0.61.

Long-Term Stock Chart Of AstraZeneca plc (ADR) (Click to enlarge)

Sanofi (NYSE:SNY) has a market capitalization of $91.59 billion. The company employs 101,575 people, generates revenues of $44,035.57 million and has a net income of $5,989.17 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $14,726.18 million. Because of these figures, the EBITDA margin is 33.44 percent (operating margin 18.59 percent and the net profit margin finally 13.60 percent).


The total debt representing 9.69 percent of the company’s assets and the total debt in relation to the equity amounts to 15.56 percent. Due to the financial situation, the return on equity amounts to 10.78 percent. Finally, earnings per share amounted to $2.44 of which $1.72 were paid in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 13.96, Price/Sales 2.09 and Price/Book ratio 1.22. Dividend Yield: 5.16 percent. The beta ratio is 0.89.

Long-Term Stock Chart Of Sanofi SA (ADR) (Click to enlarge)

Eli Lilly & (NYSE:LLY) has a market capitalization of $43.93 billion. The company employs 38,380 people, generates revenues of $23,076.00 million and has a net income of $5,069.50 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $7,793.60 million. Because of these figures, the EBITDA margin is 33.77 percent (operating margin 28.28 percent and the net profit margin finally 21.97 percent).


The total debt representing 22.34 percent of the company’s assets and the total debt in relation to the equity amounts to 55.77 percent. Due to the financial situation, the return on equity amounts to 46.20 percent. Finally, earnings per share amounted to $4.19 of which $1.96 were paid in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 9.06, Price/Sales 1.88 and Price/Book ratio 3.48. Dividend Yield: 5.23 percent. The beta ratio is 0.72.

Long-Term Stock Chart Of Eli Lilly & Co. (Click to enlarge)

Take a closer look at the full table of best dividend paying drug stocks. The average price to earnings ratio (P/E ratio) amounts to 15.3 while the forward P/E ratio is 10.5. The dividend yield has a value of 4.5 percent. Price to book ratio is 3.1 and price to sales ratio 2.2. The operating margin amounts to 21.5 percent.

Here is the table with some fundamentals (TTM):

The 10 Best Dividend Paying Drug Stocks (Click to enlarge)

Related stock ticker symbols:

AZN, SNY, LLY, GSK, MRK, NVS, BMY, PFE, ABT, JNJ

Selected Articles:

· Best Yielding Drugs Wholesale Stocks

· Five Drug Store Retailer In Comparison

· Best Pharmaceutical Shares For Income Investors

· 14 Healthcare Dividend Stocks With Biggest Institutional Buys

Best Yielding Drugs Wholesale Stocks

Here is a current sheet of the best yielding stocks from the drugs wholesale industry. In total, 6 drug wholesaler stocks are listed of which 4 have a market capitalization of more than USD 10 billion.

The average price to earnings ratio (P/E ratio) amounts to 17.55 while the average forward price to earnings ratio has a value of 13.69. In average, the dividend yield amounts to 1.14 percent. Price to book ratio is 2.53 and price to sales ratio 0.27.

Here is the table for a detailed view:
(Subscribe my RSS Feed in a reader for free or follow me on Facebook or Twitter)

Best Yielding Drug Wholesale Stocks (Click to enlarge)

Related stock ticker symbols:
CAH, ABC, MCK, OCR

Selected Articles:

· 10 High Yielding Drug Manufacturers

· Five Drug Store Retailer In Comparison

· High Yields From Healthcare Sector

· Best Dividend Paying Stock List As Of June 2011

Dividend Stock Idea of the Day – Boiron (BOI)

Our Dividend Idea of the day is Boiron (BOI), a French based pharmaceutical company. Boiron is engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and proprietary drugs. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, Institut Boiron, which works for the development of homeopathy within the world of medicine. Boiron SA operates in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.

Here are Fundamental Figures:

Sales	520.60 Mil
Income	43.27 Mil
Net Profit Margin	8.31%
Return on Equity	13.18%
Debt/Equity Ratio	0.02
Revenue/Share	24.25
Earnings/Share	2.02
Book Value/Share	16
Dividend Rate	0.7
Payout Ratio	35.00%

Here are Pricing Figures:

Price/Earnings	15.3
Price/Book	1.9
Price/Sales	1.3
Price/Cash Flow	12.9
Dividend Yield %	2.3
Forward Price/Earnings	13.2
PEG Ratio	5.9
PEG Payback (Yrs)	10.7

Here are Trading Figures:

Last Price	30.73
52-Wk High	32.25
52-Wk Low	24.16
Volume	2,700
Avg Daily Vol (13 Wks)	7,190
50-Day Moving Average	30.82
200-Day Moving Average	28.3
Volatility (beta)	0.08